Government cap on branded medicine prices may be unsustainable warns ABPI

Government cap on branded medicine prices may be unsustainable, warns ABPI

10:49 EDT 26 Apr 2019 | The Pharmaceutical Journal

An ongoing cap on the price of branded medicines to the NHS “may not be sustainable” in the long term, the Association of the British Pharmaceutical Industry has said.

More From BioPortfolio on "Government cap on branded medicine prices may be unsustainable, warns ABPI"